Analyst Ratings

Upgrades, downgrades, and outlook changes from major analysts.

Coverage of analyst actions including upgrades, downgrades, initiations, and price-target changes. This category tracks how institutional research influences market perception, momentum shifts, and short-term price behavior.

Articles

3,518 total articles

Cantor Fitzgerald Starts Coverage on Better Home & Finance, Assigns Overweight Rating and $40 Target

Cantor Fitzgerald Starts Coverage on Better Home & Finance, Assigns Overweight Rating and $40 Target

Cantor Fitzgerald initiated coverage of Better Home & Finance Holding (NASDAQ: BETR) with an Overweight rating and a $40 price target, highlighting the company's Tinman AI decision engine, a capital-light marketplace lending structure, and expanding white-label SaaS revenue. The report points to 43.8% revenue growth over the past year and models a …

KeyBanc Sticks With Overweight on Somnigroup; $105 Target Reflects Growth and Valuation Questions

KeyBanc Sticks With Overweight on Somnigroup; $105 Target Reflects Growth and Valuation Questions

KeyBanc has reaffirmed an Overweight rating on Somnigroup (NYSE: SGI) and kept a $105 12-month price target, citing market-share expansion, benefits from MFRM integration and potential upside from a proposed all-stock acquisition of Leggett & Platt. The stock trades above historical valuation norms on several metrics, and Somnigroup reports earning…

KeyBanc Keeps Sector Weight on Avista After 2025 RFP Selections; Capital Plan, Rate Filing Highlight Path Forward

KeyBanc Keeps Sector Weight on Avista After 2025 RFP Selections; Capital Plan, Rate Filing Highlight Path Forward

KeyBanc has reaffirmed a Sector Weight rating on Avista (AVA) after the utility announced the winners of its 2025 Request for Proposals. The selected portfolio, which combines company-owned resources and power purchase agreements, is expected to drive $250 million to $350 million of incremental capital and may support an uplift to Avista's long-ter…

Piper Sandler Sticks With Overweight on Stryker Ahead of Q4 Results, Sees Upside From New Handheld Robot

Piper Sandler Sticks With Overweight on Stryker Ahead of Q4 Results, Sees Upside From New Handheld Robot

Piper Sandler has maintained an Overweight rating and a $420 price target on Stryker, positioning the stock for roughly 18% upside from its current level as the company prepares to report fourth-quarter results. The firm cites a newly previewed handheld orthopedic robot - identified as Mako RPS after patent review and physician feedback - as a pote…